Philadelphia Trust CO Vertex Pharmaceuticals Inc Transaction History

Philadelphia Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$221.42 - $260.97 $5.98 Million - $7.04 Million	-26,985 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $4.44 Million - $5.61 Million	25,100 Added 1331.56%	26,985 $5.93 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $3.41 Million - $3.82 Million	-18,810 Reduced 90.89%	1,885 $342,000
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $3.88 Million - $4.58 Million	20,695 New	20,695 $4.17 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $1.43 Million - $1.67 Million	-6,930 Closed	0 $0

Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $1.43 Million - $1.91 Million	6,930 New	6,930 $1.64 Million

1,623

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

Stay updated on Philadelphia Trust CO with notifications on news.